Skip to Main Content
Skip Nav Destination

Chapter 2 elaborates a politics of civil society advocacy against unethical clinical trials in India as it developed through public scandal. It focuses upon a study conducted to facilitate the rollout of the human papilloma virus (HPV) vaccine into India’s national immunization program, which generated enormous controversy and became a fulcrum around which a broader politics concerned with clinical trials in India emerged. This raises questions not just about relationships between health, value, and politics, but also of the configuration of epidemiological knowledge and technocratic forms of governance within these relationships.

This content is only available as PDF.
You do not currently have access to this chapter.
Don't already have an account? Register
Close Modal

or Create an Account

Close Modal
Close Modal